Ian Rentsch

Vice President Strategic Partnerships - Enterprise Global Clinical Development @Fortrea

Berlin, DE
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Apr 2025 — Present

Vice President Strategic Partnerships - Enterprise Global Clinical Development @Fortrea

View department →

Berlin, DE

Fortrea (Nasdaq: FTRE) is a leading global Contract Research Organization (CRO) providing Phase I-IV clinical trial management, clinical pharmacology, and consulting to pharmaceutical and medical device companies. Spun off from Labcorp/Covance, it has over 30 years of experience, operating in ~100 countries with expertise in 20+ therapeutic areas to accelerate drug development.

EDUCATION

1982 — 1993

Goethe Schule Buenos Aires

Bachelor, Humanistics

2002 — 2002

University of Buenos Aires

Postgraduate Degree, Corporate Law

1996 — 1997

Argentine / German Chamber of Commerce (IHK)

Industriekaufmann (IK), Industrial Administration

1994 — 1999

University of Buenos Aires

J.D. (Attorney), Specialized in Corporate Law

2002

University of Buenos Aires

Postgraduate Degree, International contracts in Mercosur

SKILLS

CROOncologyNegotiationPharmaceutical IndustrySopFdaClinical ResearchIch-GcpLatin AmericaManagementEdcCtmsRegulatory AffairsLifesciencesClinical TrialsStrategyDiabetesDrug DevelopmentContract NegotiationStart-UpsGcpStrategic PlanningInfectious DiseasesBiotechnologyCorporate DevelopmentBusiness DevelopmentNeurologyEmerging MarketsClinical MonitoringClinical Trial Management System (Ctms)Life SciencesLegal Affairs / Finance EngineeringInternational Sales / Business DevelopmentClinical Data ManagementStart-Ups / Corporate DevelopmentElectronic Data Capture (Edc)Clinical DevelopmentCRO ManagementLeadershipGood Clinical Practice (Gcp)

ABOUT IAN RENTSCH

I’m a commercially driven BioPharma executive with 25+ years of experience scaling RWE and rare disease ventures from early stage to global commercial success. As Chief Commercial Officer at Centogene and a senior leader at IQVIA, Aetion, and executive leader at Clinerion & Trinetx I’ve led organizations through complex growth inflection points—defining global GTM strategies, establishing pharma alliances, and building commercial teams across Europe, the US, and Asia.My track record includes launching multi million pharma partnerships, growing revenue by double digits, and creating high-impact RWE consortia like ROPAD at Centogene. I’ve led major P&L units, owned investor relationships, and navigated both organic and M&A-driven expansion. Whether repositioning a legacy business or scaling a digital health solution, I specialize in architecting growth and aligning commercial vision with execution.What drives me is building purpose-driven, commercially sustainable businesses that accelerate access to precision medicine. I lead with clarity, conviction, and a collaborative edge—cultivating cultures where data, talent, and market forces converge to unlock industry-first innovation. As a board advisor and frequent industry speaker, I help early- and growth-stage ventures sharpen their story and scale with intention.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.